RISA CLAYTON: Open Payments
NPI 1376272823 · BRANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 22 payments from 9 companies in 2025. Trend: 2023 $66 · 2024 $323 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $220 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| PFIZER INC. | 2 | $37 |
| Philips North America LLC | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: MOUNJARO, AIRSUPRA, PREVNAR 20, ZEPBOUND, Extended Holter, QULIPTA, SHINGRIX, Ozempic.
Industry payments across FL — which companies pay providers there.
